Literature DB >> 15146203

[Prevalence of microalbuminuria in a hypertensive population of northerm Navarre and its relation to other cardiovascular risk factors].

B Aguirre1.   

Abstract

AIM: To determine the prevalence of microalbuminuria in a hypertense population in northern Navarre and its relationship to other cardiovascular risk factors. PATIENTS AND METHODS: All the known hypertensive patients in our area of work were included, and a transversal study was designed that also evaluated the presence of other cardiovascular risk factors, including diabetes mellitus, hypercholesterolemia, obesity, smoking and alcohol drinking.
RESULTS: A total of 106 hypertensive patients (54.7% women) were studied. The presence of microalbuminuria was found in 19 patients (18%), and a significant percentage showed other cardiovascular risk factors - diabetes mellitus (24.5%), hypercholesterolemia (61.3%), and obesity (49%). In 12.2% there was a concurrence of arterial hypertension, diabetes mellitus, hypercholesterolemia and obesity. Eighty-four percent of the diabetics were type 2. The highest percentage of cardiovascular risk factors corresponded to the group of hypertensive patients with positive microalbuminuria, and the most significant differences were found in the group of diabetics.
CONCLUSIONS: The frequency of microalbuminuria in our hypertensive population was similar to that reported in other papers. A high prevalence of cardiovascular risk factors was found, especially in the group of hypertensive patients with positive microalbuminuria.

Entities:  

Mesh:

Year:  2004        PMID: 15146203     DOI: 10.4321/s1137-66272004000100004

Source DB:  PubMed          Journal:  An Sist Sanit Navar        ISSN: 1137-6627            Impact factor:   0.829


  1 in total

1.  [Microalbuminuria in hypertensive patients in primary care].

Authors:  Alberto Martínez Castelao; Verónica Duarte-Gallego; Itziar Navarro-Zorita; Jordi Galera Llorca
Journal:  Aten Primaria       Date:  2008-12-24       Impact factor: 1.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.